Jeffrey H. Nicholas was featured in the ACG Philadelphia article, “DealWire: Closing Q4 Deals.” View the full article in the February 1, 2016, issue, but a synopsis is below.

Fox Rothschild’s Jeff Nicholas was noted for representing Philadelphia-based ReliefBand Technologies LLC in a $5 million Series A funding. The round, which was led by Chicago-based PathoCapital, will help fund the introduction of the company’s new wearable device that is intended to treat nausea.

^{As this article contains statements regarding past performance, please note that results may vary depending on your particular facts and legal circumstances.}